| (24) Medical waste - Waste generated by health-care-related
facilities and associated with health-care activities, not including garbage
or rubbish generated from offices, kitchens, or other non-health-care activities.
The term includes special waste from health-care-related facilities which
is comprised of animal waste, bulk blood and blood products, microbiological
waste, pathological waste, and sharps as those terms are defined in 25 TAC §1.132
(relating to Definition, Treatment, and Disposition of Special Waste from
Health-Care Related Facilities). The term does not include medical waste produced
on farmland or ranchland as defined in Texas Agriculture Code, §252.001(6)
(relating to Definitions - Farmland or Ranchland), nor does the term include
artificial, nonhuman materials removed from a patient and requested by the
patient including, but not limited to, orthopedic devices and breast implants.
(25) Medical/infectious waste - Any waste generated in
the diagnosis, treatment, or immunization of human beings or animals, in research
pertaining thereto, or in the production or testing of the following biologicals:
(A) cultures and stocks of infectious agents and associated
biologicals, including: cultures from medical and pathological laboratories;
cultures and stocks of infectious agents from research and industrial laboratories;
wastes from the production of biologicals; discarded live and attenuated vaccines;
and culture dishes and devices used to transfer, inoculate, and mix cultures;
(B) human pathological waste, including: tissues; organs; and
body parts and body fluids that are removed during surgery or autopsy, or
other medical procedures; and specimens of body fluids and their containers;
(C) human blood and blood products, including: liquid waste
human blood; products of blood; items saturated and/or dripping with human
blood; or items that were saturated and/or dripping with human blood that
are now caked with dried human blood; including serum, plasma, and other blood
components, and their containers, which were used or intended for use in either
patient care, testing and laboratory analysis, or the development of pharmaceuticals.
Intravenous bags are also included in this category;
(D) sharps that have been used in animal or human patient care
or treatment or in medical, research, or industrial laboratories, including:
hypodermic needles; syringes (with or without the attached needle); Pasteur
pipettes; scalpel blades; blood vials; needles with attached tubing; and culture
dishes (regardless of presence of infectious agents). Also included are other
types of broken or unbroken glassware that were in contact with infectious
agents, such as slides and cover slips;
(E) animal waste, including: contaminated animal carcasses,
body parts, and bedding of animals that were known to have been exposed to
infectious agents during research (including research in veterinary hospitals);
production of biologicals; or testing of pharmaceuticals;
(F) isolation wastes, including: biological waste and discarded
materials contaminated with blood, excretions, exudates, or secretions from
humans who are isolated to protect others from certain highly communicable
diseases, or isolated animals known to be infected with highly communicable
diseases;
(G) unused sharps, including the following unused, discarded
sharps: hypodermic needles; suture needles; syringes; and scalpel blades;
and
(H) does not include: hazardous waste identified or listed
under the regulations in Title 40 Code of Federal Regulations Part 261 (40
CFR 261); household waste, as identified in 40 CFR 261.4(b)(1); ash from incineration
of medical/infectious waste, once the incineration process has been completed;
human corpses, remains, and anatomical parts that are intended for interment
or cremation; and domestic sewage materials identified in 40 CFR 261.4(a)(1).
(26) Minimum sorbent flow rate - 90% of the highest
three-hour average sorbent flow rate (taken, at a minimum, once every hour)
measured during the most recent performance test demonstrating compliance
with the applicable (dioxin/furan, mercury, and hydrogen chloride) emission
limit.
(27) Minimum wet scrubber parameters - 90% of the highest
three-hour average scrubber parameter (taken, at a minimum, once every minute)
measured during the most recent performance test demonstrating compliance
with the applicable emission limits. The parameters include:
(A) horsepower or amperage to the scrubber;
(B) pressure drop across the wet scrubber;
(C) liquid flow rate at the scrubber inlet; and
(D) liquid pH at the scrubber inlet.
(28) Minimum secondary chamber temperature - 90%
of the highest three-hour average secondary chamber temperature (taken, at
a minimum, once every minute) measured during the most recent performance
test demonstrating compliance with the particulate matter, carbon monoxide,
or dioxin/furan emission limits.
(29) Modification (or modified incinerator) - Any change
to an incinerator unit after the effective date of these standards such that:
(A) the cumulative costs of the modifications, over the life
of the unit, exceed 50% of the original cost of the construction and installation
of the unit (not including the cost of any land purchased in connection with
such construction or installation) updated to current costs; or
(B) the change involves a physical change in or change in the
method of operation of the unit which increases the amount of any air pollutant
emitted by the unit for which standards have been established under the FCAA,
42 United States Code, §7411 or §7429.
(30) Operating day - A 24-hour period between 12:00
a.m., midnight and the following midnight during which any amount of hospital
waste or medical/infectious waste is combusted at any time in the incinerator.
(31) Operation - The period during which waste is combusted
in the incinerator excluding periods of startup or shutdown.
(32) Particulate matter - The total particulate matter
emitted from an incinerator as measured by EPA Reference Method 5, concerning
Determination of Particulate Emissions from Stationary Sources (40 CFR 60,
Appendix A, 1999), or Reference Method 29, concerning Determination of Metals
Emissions from Stationary Sources (40 CFR 60, Appendix A, 1999).
(33) Pathological waste - Waste material consisting of
only human or animal remains, anatomical parts, and/or tissue, the bags/containers
used to collect and transport the waste material, and animal bedding (if applicable).
(34) Primary chamber - The chamber in an incinerator that
receives waste material in which the waste is ignited and from which ash is
removed.
(35) Pyrolysis - The endothermic gasification of hospital
waste and/or medical/infectious waste using external energy.
(36) Shutdown - The period of time after all waste has
been combusted in the primary chamber. For continuous incinerators, shutdown
shall commence no less than two hours after the last charge to the incinerator.
For intermittent incinerators, shutdown shall commence no less than four hours
after the last charge to the incinerator. For batch incinerators, shutdown
shall commence no less than five hours after the high-air phase of combustion
has been completed.
(37) Standard conditions - A temperature of 68 degrees
Fahrenheit (20 degrees Centigrade) and a pressure of 14.7 pounds per square
inch (101.3 kilopascals).
(38) Startup - The period of time between the activation
of the system and the first charge to the unit. For batch incinerators, startup
is the period of time between activation of the system and ignition of the
waste.
(39) Toxic equivalent quantity (TEQ) - For dioxins/furans,
a TEQ basis=2,3,7,8-tetrachlorinated dibenzo-p-dioxin toxic equivalent based
on the 1989 international toxic equivalency factors.
(40) Wet scrubber - An add-on air pollution control device
that utilized an alkaline scrubbing liquor to collect particulate matter (including
non-vaporous metals and condensed organics) and/or to absorb and neutralize
acid gases.
|
